Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
190.60 USD | -1.23% |
|
+3.64% | +7.26% |
02-07 | Abbvie Says FDA Approves Treatment For Intra-Abdominal Infections | RE |
02-07 | AbbVie Gets FDA Approval of Intravenous Antibiotic Emblaveo | DJ |
EPS & Dividend: AbbVie Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | 4.39 | 4.84 | 5.31 | 5.71 | 5.99 | 6.226 | 6.546 | 6.851 |
Rate of return | 4.96% | 4.52% | 3.92% | 3.53% | 3.87% | 3.27% | 3.43% | 3.59% |
EPS 2 | 5.28 | 2.72 | 6.45 | 6.63 | 2.72 | 2.39 | 7.462 | 9.047 |
Distribution rate | 83.1% | 178% | 82.3% | 86.1% | 220% | 141% | 87.7% | 75.7% |
Reference price 2 | 88.54 | 107.15 | 135.40 | 161.61 | 154.97 | 190.60 | 190.60 | 190.60 |
Nbr of stocks (in thousands) | 1,478,821 | 1,765,474 | 1,767,880 | 1,767,880 | 1,765,537 | 1,767,140 | 1,767,140 | - |
Announcement Date | 2/7/20 | 2/3/21 | 2/2/22 | 2/9/23 | 2/2/24 | 1/31/25 | - | - |
Past dividends: AbbVie Inc.
2025-01-14 | Quarterly 1.64 USD |
2024-10-14 | Quarterly 1.55 USD |
2024-07-14 | Quarterly 1.55 USD |
2024-04-11 | Quarterly 1.55 USD |
2024-01-11 | Quarterly 1.55 USD |
2023-10-11 | Quarterly 1.48 USD |
2023-07-12 | Quarterly 1.48 USD |
2023-04-12 | Quarterly 1.48 USD |
2023-01-11 | Quarterly 1.48 USD |
2022-10-12 | Quarterly 1.41 USD |
2022-07-13 | Quarterly 1.41 USD |
2022-04-12 | Quarterly 1.41 USD |
2022-01-12 | Quarterly 1.41 USD |
2021-10-13 | Quarterly 1.3 USD |
2021-07-13 | Quarterly 1.3 USD |
2021-04-13 | Quarterly 1.3 USD |
2021-01-13 | Quarterly 1.3 USD |
2020-10-13 | Quarterly 1.18 USD |
2020-07-13 | Quarterly 1.18 USD |
2020-04-13 | Quarterly 1.18 USD |
Upcoming events: AbbVie Inc.
2025-04-24 | Q1 2025 Earnings Release (Projected) |
2025-07-24 | Q2 2025 Earnings Release (Projected) |
2025-10-23 | Q3 2025 Earnings Release (Projected) |
2026-02-03 | Q4 2025 Earnings Release (Projected) |
Yield (Y) | Yield (Y+1) | P/E ratio (Y) | Price to Book (Y) | EV / Sales (Y) | ||
---|---|---|---|---|---|---|
3.27% | 3.43% | 43.27x | 46.56x | 7.06x | ||
0.59% | 0.67% | 71.35x | 47.15x | 18.03x | ||
2.2% | 2.67% | 22.95x | 13.56x | 8.11x | ||
3.11% | 3.29% | 22.11x | 5.17x | 4.28x | ||
3.42% | 3.5% | 15.07x | 5.86x | 3.75x | ||
2.16% | 2.24% | 26.98x | 5.4x | 4.6x | ||
3.52% | 3.73% | 12.45x | 4.7x | 3.8x | ||
3.58% | 3.78% | 16.71x | 4.66x | 4.2x | ||
3.08% | 3.27% | 32.15x | 24.27x | 6.24x | ||
6.47% | 6.6% | 15.12x | 1.64x | 3.24x | ||
Average | percentage-no-prefix | percentage-no-prefix | 27.82x | 15.90x | 6.33x | |
Weighted average by Cap. | percentage-no-prefix | percentage-no-prefix | 35.99x | 22.26x | 8.56x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -

MarketScreener is also available in this country: United States.
Switch edition